Literature DB >> 22787209

Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Tomoko Date1, Takanobu Kato, Junko Kato, Hitoshi Takahashi, Kenichi Morikawa, Daisuke Akazawa, Asako Murayama, Keiko Tanaka-Kaneko, Tetsutaro Sata, Yasuhito Tanaka, Masashi Mizokami, Takaji Wakita.   

Abstract

Although the recently developed infectious hepatitis C virus system that uses the JFH-1 clone enables the study of whole HCV viral life cycles, limited particular HCV strains have been available with the system. In this study, we isolated another genotype 2a HCV cDNA, the JFH-2 strain, from a patient with fulminant hepatitis. JFH-2 subgenomic replicons were constructed. HuH-7 cells transfected with in vitro transcribed replicon RNAs were cultured with G418, and selected colonies were isolated and expanded. From sequencing analysis of the replicon genome, several mutations were found. Some of the mutations enhanced JFH-2 replication; the 2217AS mutation in the NS5A interferon sensitivity-determining region exhibited the strongest adaptive effect. Interestingly, a full-length chimeric or wild-type JFH-2 genome with the adaptive mutation could replicate in Huh-7.5.1 cells and produce infectious virus after extensive passages of the virus genome-replicating cells. Virus infection efficiency was sufficient for autonomous virus propagation in cultured cells. Additional mutations were identified in the infectious virus genome. Interestingly, full-length viral RNA synthesized from the cDNA clone with these adaptive mutations was infectious for cultured cells. This approach may be applicable for the establishment of new infectious HCV clones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22787209      PMCID: PMC3457305          DOI: 10.1128/JVI.07235-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

2.  Biological properties of purified recombinant HCV particles with an epitope-tagged envelope.

Authors:  Hitoshi Takahashi; Daisuke Akazawa; Takanobu Kato; Tomoko Date; Masayuki Shirakura; Noriko Nakamura; Hidenori Mochizuki; Keiko Tanaka-Kaneko; Tetsutaro Sata; Yasuhito Tanaka; Masashi Mizokami; Tetsuro Suzuki; Takaji Wakita
Journal:  Biochem Biophys Res Commun       Date:  2010-04-23       Impact factor: 3.575

3.  Evaluation of hepatitis C virus core antigen assays in detecting recombinant viral antigens of various genotypes.

Authors:  Mohsan Saeed; Ryosuke Suzuki; Madoka Kondo; Hideki Aizaki; Takanobu Kato; Toshiaki Mizuochi; Takaji Wakita; Haruo Watanabe; Tetsuro Suzuki
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

4.  Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus.

Authors:  Nobuhiko Hiraga; Hiromi Abe; Michio Imamura; Masataka Tsuge; Shoichi Takahashi; C Nelson Hayes; Hidenori Ochi; Chise Tateno; Katsutoshi Yoshizato; Yusuke Nakamura; Naoyuki Kamatani; Kazuaki Chayama
Journal:  Hepatology       Date:  2011-08-02       Impact factor: 17.425

5.  Production and characterization of HCV particles from serum-free culture.

Authors:  Daisuke Akazawa; Kenichi Morikawa; Noriaki Omi; Hitoshi Takahashi; Noriko Nakamura; Hidenori Mochizuki; Tomoko Date; Koji Ishii; Tetsuro Suzuki; Takaji Wakita
Journal:  Vaccine       Date:  2011-05-07       Impact factor: 3.641

6.  Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient.

Authors:  T Kato; A Furusaka; M Miyamoto; T Date; K Yasui; J Hiramoto; K Nagayama; T Tanaka; T Wakita
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

7.  RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells.

Authors:  Asako Murayama; Leiyun Weng; Tomoko Date; Daisuke Akazawa; Xiao Tian; Tetsuro Suzuki; Takanobu Kato; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita; Tetsuya Toyoda
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

8.  Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection.

Authors:  Hideki Aizaki; Kenichi Morikawa; Masayoshi Fukasawa; Hiromichi Hara; Yasushi Inoue; Hideki Tani; Kyoko Saito; Masahiro Nishijima; Kentaro Hanada; Yoshiharu Matsuura; Michael M C Lai; Tatsuo Miyamura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

9.  Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.

Authors:  Takanobu Kato; Youkyung Choi; Gamal Elmowalid; Ronda K Sapp; Heidi Barth; Akihiro Furusaka; Shunji Mishiro; Takaji Wakita; Krzysztof Krawczynski; T Jake Liang
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

10.  Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations.

Authors:  Thomas Pietschmann; Margarita Zayas; Philip Meuleman; Gang Long; Nicole Appel; George Koutsoudakis; Stephanie Kallis; Geert Leroux-Roels; Volker Lohmann; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more
  17 in total

1.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.

Authors:  Ulrike Breitinger; Noha S Farag; Nourhan K M Ali; Hans-Georg A Breitinger
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

3.  Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient.

Authors:  Huang Cao; Wandi Zhu; Qingxia Han; Rongjuan Pei; Xinwen Chen
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

4.  Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.

Authors:  Yi-Ping Li; Santseharay Ramirez; Sanne B Jensen; Robert H Purcell; Judith M Gottwein; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

5.  Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.

Authors:  Asako Murayama; Nao Sugiyama; Ryosuke Suzuki; Masaki Moriyama; Noriko Nakamura; Hidenori Mochizuki; Takaji Wakita; Takanobu Kato
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment.

Authors:  Elena Moreno; Isabel Gallego; Josep Gregori; Adriana Lucía-Sanz; María Eugenia Soria; Victoria Castro; Nathan M Beach; Susanna Manrubia; Josep Quer; Juan Ignacio Esteban; Charles M Rice; Jordi Gómez; Pablo Gastaminza; Esteban Domingo; Celia Perales
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

7.  Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance.

Authors:  Sanne B Jensen; Stéphanie B N Serre; Daryl G Humes; Santseharay Ramirez; Yi-Ping Li; Jens Bukh; Judith M Gottwein
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

8.  Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.

Authors:  Yi-Ping Li; Santseharay Ramirez; Lotte Mikkelsen; Jens Bukh
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

9.  Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.

Authors:  Judith M Gottwein; Sanne B Jensen; Stéphanie B N Serre; Lubna Ghanem; Troels K H Scheel; Tanja B Jensen; Henrik Krarup; Nathalie Uzcategui; Lotte S Mikkelsen; Jens Bukh
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

10.  Novel permissive cell lines for complete propagation of hepatitis C virus.

Authors:  Mai Shiokawa; Takasuke Fukuhara; Chikako Ono; Satomi Yamamoto; Toru Okamoto; Noriyuki Watanabe; Takaji Wakita; Yoshiharu Matsuura
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.